Annovis Bio: Should Still Be On Your Watchlist
Xesai/E+ via Getty Images
There has been a call by acting FDA Commissioner Janet Woodcock for an investigation into the approval of Biogen’s (NASDAQ: BIIB) and Eisai’s (OTCPK: ESALF) Aduhelm (aducanumab).
This approval obtained in the first week of June,…
